Patent · US Active

Indazole and pyrazolopyridine compounds as CCR1 receptor antagonists

US9056858B2 · kind B2 · utility

0Cited by

36References

17Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Brian Nicholas Cook · Danbury, US
Daniel Kuzmich · Clovis, US
Can Mao · Philadelphia, US
Hossein Razavi · Danbury, US

Key dates

Filing date	Oct 19, 2010
Grant date	Jun 16, 2015
Priority date	—
Expiry date	Apr 30, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D471/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are CCR1 receptor antagonists of the formula (I)wherein Ar1, Ar2, R1, X and G are disclosed herein. Also disclosed are compositions, methods of making and using compounds of the formula (I).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.